Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 42451-42500 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05726890
Examining the Effectiveness of Two Behavioral Interventions for Sleep Problems in Infants
NARecruiting
230 participants
Started: Mar 9, 2023 · Completed: Sep 30, 2028
1 condition1 sponsor1 location
NCT05782478
Added Diagnostic Value of Point of Care Ultrasound in Acute Dyspnea
N/ARecruiting
160 participants
Started: Mar 9, 2023 · Completed: Mar 28, 2026
2 conditions1 sponsor2 locations
NCT05751343
TACE-HAIC Plus Atezolizumab and Bevacizumab for Unresectable Advanced HCC: a Phase 2 Clinical Trial
PHASE2Recruiting
55 participants
Started: Mar 9, 2023 · Completed: Sep 28, 2025
1 condition1 sponsor1 location
NCT06784440
"Search for Noninvasive Markers of Graft Injury in Pediatric and Adult Patients With Congenital Heart Disease Undergoing Cardiac Transplantation"
NARecruiting
20 participants
Started: Mar 8, 2023 · Completed: Mar 7, 2026
4 conditions1 sponsor1 location
NCT05259904
Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation
PHASE2Recruiting
75 participants
Started: Mar 8, 2023 · Completed: Oct 31, 2028
2 conditions3 sponsors1 location
NCT05477823
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
EARLY_PHASE1Recruiting
30 participants
Started: Mar 8, 2023 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT05425511
WELL-being Improvement Following a SOphrology Intervention in Hospital Staff
NARecruiting
200 participants
Started: Mar 8, 2023 · Completed: Mar 31, 2028
3 conditions3 sponsors1 location
NCT06718205
Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma
PHASE2Recruiting
112 participants
Started: Mar 8, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT04372875
Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: a Pragmatic Trial
NARecruiting
37,500 participants
Started: Mar 8, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05629533
The Nanowear Wearable System SimpleSense Validation Trial for Cardiac Output
N/ARecruiting
100 participants
Started: Mar 8, 2023 · Completed: Dec 1, 2024
1 condition2 sponsors1 location
NCT05238285
Production of Nonverbal Acoustic Signals and Resulting Physiological Responses
N/ARecruiting
2,000 participants
Started: Mar 8, 2023 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT06005168
Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis
PHASE4Recruiting
104 participants
Started: Mar 8, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05366218
Tafasitamab (MOR00208) in Pediatric Patients with Relapsed or Refractory Acute B Lineage Leukemia
PHASE1/PHASE2Recruiting
20 participants
Started: Mar 8, 2023 · Completed: Mar 31, 2027
3 conditions1 sponsor11 locations
NCT05432024
Evaluation of Ablation Lesions Using Cardiovascular Magnetic Resonance Imaging
N/ARecruiting
60 participants
Started: Mar 8, 2023 · Completed: Apr 1, 2028
1 condition1 sponsor1 location
NCT06437158
Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients
PHASE2Recruiting
200 participants
Started: Mar 8, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05689866
Study of Bladder-sphincter Symptoms in Functional Neurological Disorders
N/ARecruiting
150 participants
Started: Mar 8, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05668598
Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics
NARecruiting
60 participants
Started: Mar 8, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05733000
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
PHASE2Recruiting
94 participants
Started: Mar 8, 2023 · Completed: Mar 4, 2030
33 conditions2 sponsors1 location
NCT06992271
Comparing Two Eccentric Protocols on Muscle Damage
NARecruiting
16 participants
Started: Mar 8, 2023 · Completed: Jun 1, 2025
2 conditions1 sponsor1 location
NCT05799001
Dance Workshop for Institutionalized Seniors With Behavioral and Psychological Symptoms of Dementia
NARecruiting
180 participants
Started: Mar 8, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor2 locations
NCT05670496
Collection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Disorders.
N/ARecruiting
600 participants
Started: Mar 8, 2023 · Completed: Dec 1, 2032
2 conditions1 sponsor1 location
NCT05868707
OH2 Injection in Melanoma
PHASE3Recruiting
340 participants
Started: Mar 8, 2023 · Completed: Mar 31, 2027
1 condition1 sponsor30 locations
NCT05673694
To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.
PHASE1Recruiting
70 participants
Started: Mar 8, 2023 · Completed: Jan 2, 2026
1 condition1 sponsor5 locations
NCT06108661
Effects of ELDOA and Slump Stretching on Mechanical Low Back Pain
NARecruiting
38 participants
Started: Mar 7, 2023 · Completed: Dec 15, 2023
1 condition1 sponsor1 location
NCT05664516
A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder
PHASE2Recruiting
60 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05858242
Study on Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast Cancer
N/ARecruiting
100 participants
Started: Mar 7, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05728814
DOstarlimab in Patients With Recurrent or dMMR/MSI-H Endometrial Cancer
N/ARecruiting
100 participants
Started: Mar 7, 2023 · Completed: Sep 12, 2024
1 condition1 sponsor1 location
NCT05742698
Nabilone for Agitation in Frontotemporal Dementia
PHASE2Recruiting
45 participants
Started: Mar 7, 2023 · Completed: May 31, 2026
6 conditions2 sponsors7 locations
NCT06444971
Effects of Post-isometric Relaxation Technique on Chest Expansion and Pulmonary Function Tests in Smokers
NARecruiting
40 participants
Started: Mar 7, 2023 · Completed: Jun 27, 2024
1 condition1 sponsor1 location
NCT05149859
Compuls-BED-Severity
N/ARecruiting
200 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors2 locations
NCT05786716
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
PHASE2/PHASE3Recruiting
30 participants
Started: Mar 7, 2023 · Completed: Oct 31, 2029
11 conditions5 sponsors27 locations
NCT05842551
Prismatic Lenses and tDCS in Neglect
NARecruiting
30 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06511648
Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations
PHASE2Recruiting
90 participants
Started: Mar 7, 2023 · Completed: Mar 31, 2029
1 condition3 sponsors19 locations
NCT05439083
Immunogenicity of 9-valent HPV Vaccine
PHASE4Recruiting
120 participants
Started: Mar 7, 2023 · Completed: Mar 1, 2025
1 condition1 sponsor1 location
NCT04685317
Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation
NARecruiting
48 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06127433
The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 Diabetes
PHASE4Recruiting
210 participants
Started: Mar 7, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05414448
Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection
NARecruiting
1,726 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT05905705
Disruptions of Brain Networks and Sleep by Electroconvulsive Therapy
N/ARecruiting
50 participants
Started: Mar 7, 2023 · Completed: Jul 31, 2027
1 condition2 sponsors1 location
NCT04128072
Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma
PHASE2Recruiting
43 participants
Started: Mar 7, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor13 locations
NCT05742932
Study Evaluating the Performance and Safety of Global D Implants Indicated for Trauma Surgery (CMF-TRAUMA)
N/ARecruiting
102 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor2 locations
NCT05764759
Investigating Novel Smoking Cessation Primary Care Interventions in Rural Environments
NARecruiting
288 participants
Started: Mar 7, 2023 · Completed: Aug 15, 2027
1 condition2 sponsors1 location
NCT05765825
Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC
PHASE2Recruiting
61 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor8 locations
NCT05707078
PET/CT Follow up for Head and Neck Squamous Cell Carcinoma
NARecruiting
600 participants
Started: Mar 7, 2023 · Completed: Dec 30, 2030
2 conditions1 sponsor1 location
NCT05360095
Comparing Game Facilitated Interactivity to Genetic Counseling for Prenatal Screening Education
NARecruiting
1,125 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2025
5 conditions2 sponsors3 locations
NCT05688215
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
PHASE1/PHASE2Recruiting
56 participants
Started: Mar 7, 2023 · Completed: Mar 2, 2026
2 conditions2 sponsors1 location
NCT05651594
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
PHASE2Recruiting
40 participants
Started: Mar 7, 2023 · Completed: Mar 30, 2026
11 conditions2 sponsors1 location
NCT05811975
KSX01-TCRT Injection Project in Solid Tumors
EARLY_PHASE1Recruiting
50 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT06128278
Acute Equol Supplementation and Vascular Function in Women With and Without CKD
PHASE2Recruiting
38 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05633056
An Adaptive Randomized Controlled Trial
NARecruiting
360 participants
Started: Mar 7, 2023 · Completed: Apr 30, 2029
2 conditions3 sponsors1 location
NCT05761782
Engaging Diverse and Underserved Communities in Cancer Awareness Training and Education
N/ARecruiting
1,500 participants
Started: Mar 7, 2023 · Completed: Mar 7, 2025
1 condition1 sponsor1 location